Chronic treatment with quercetin does not inhibit angiotensin-converting Enzyme in Vivo or in Vitro

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 4, 2010, Pages 825-829

  Neto Neves, Evandro Manoel ^a   Montenegro, Marcelo F ^a   Dias Junior, Carlos A ^b   Spiller, Fernando ^a   Kanashiro, Alexandre ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; QUERCETIN;

ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INJECTIONS, INTRAPERITONEAL; MALE; PEPTIDYL-DIPEPTIDASE A; QUERCETIN; RATS; RATS, WISTAR;

RATTUS;

EID: 77956800515     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00583.x     Document Type: Article

References (23)

1. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007 137 : 2405 11.
2. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 2008 88 : 1018 25.
3. Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009 102 : 1065 74.
4. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009 61 : 67 75.
5. Ajay M, Achike FI, Mustafa AM, Mustafa MR. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2006 73 : 1 7. (Pubitemid 43765564)
6. Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001 133 : 117 24.
7. Machha A, Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 2005 46 : 36 40.
8. Duarte J, Jimenez R, O'Valle F, Galisteo M, Perez-Palencia R, Vargas F et al. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 2002 20 : 1843 54.
9. Galisteo M, Garcia-Saura MF, Jimenez R, Villar IC, Wangensteen R, Zarzuelo A et al. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil. Planta Med 2004 70 : 334 41.
10. Garcia-Saura MF, Galisteo M, Villar IC, Bermejo A, Zarzuelo A, Vargas F et al. Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol Cell Biochem 2005 270 : 147 55.
11. Perez-Vizcaino F, Bishop-Bailley D, Lodi F, Duarte J, Cogolludo A, Moreno L et al. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun 2006 346 : 919 25.
12. Erdos EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987 56 : 345 8.
13. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 2006 54 : 229 34.
14. Montenegro MF, Pessa LR, Tanus-Santos JE. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. Eur J Pharmacol 2009 607 : 173 7.
15. Oh H, Kang DG, Kwon JW, Kwon TO, Lee SY, Lee DB et al. Isolation of angiotensin converting enzyme (ACE) inhibitory flavonoids from Sedum sarmentosum. Biol Pharm Bull 2004 27 : 2035 7.
16. Hackl LP, Cuttle G, Dovichi SS, Lima-Landman MT, Nicolau M. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I. Pharmacology 2002 65 : 182 6.
17. Mackraj I, Govender T, Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. J Cardiovasc Pharmacol 2008 51 : 239 45.
18. Tanus-Santos JE, Gordo WM, Francisco-DoPrado J, Sampaio RC, Moreno H. Endothelin-1 attenuates bradykinin-induced hypotension in rats. Eur J Pharmacol 2000 397 : 367 71.
19. Li J, Wang ZW, Zhang L, Liu X, Chen XH, Bi KS. HPLC analysis and pharmacokinetic study of quercitrin and isoquercitrin in rat plasma after administration of Hypericum japonicum thunb. extract. Biomed Chromatogr 2008 22 : 374 8.
20. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet 1991 16 : 249 55.
21. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998 275 : R212 9.
22. Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006 24 : 75 84.
23. Carlstrom J, Symons JD, Wu TC, Bruno RS, Litwin SE, Jalili T. A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. J Nutr 2007 137 : 628 33.